ACCESS CMD
Accelerating Cardiometabolic Research at Scale
Cardiometabolic diseases including obesity, type 2 diabetes, hypertension, hyperlipidemia and cerebrovascular disease represent one of the largest and fastest-growing therapeutic areas globally.
Sponsors need faster recruitment, stronger real-world evidence, and longitudinal outcomes data without adding complexity to healthcare providers.
Sponsors need faster recruitment, stronger real-world evidence, and longitudinal outcomes data without adding complexity to healthcare providers.
ACCESS CMD
AccessCMD within the ACCESS Infrastructure
AccessCMD is a cardiometabolic cohort embedded within the ACCESS research-ready infrastructure across the US and UK. Using secure integration with electronic health records (EHRs), eligible individuals receiving routine care are identified and invited to participate. With consent, longitudinal clinical data are linked with ongoing patient-reported outcomes and, where relevant, home-collected biomarker or genetic data.
The result is a scalable, healthcare-embedded cohort designed for commercial research.
Get in touchThe result is a scalable, healthcare-embedded cohort designed for commercial research.
What is AccessCMD
Embedded in Care. Designed for scale.
AccessCMD is a disease-specific cohort embedded within a scalable clinical research infrastructure designed to support commercial and academic partnerships. Participants are supported by dedicated specialist nurse teams, enabling high engagement and data completeness without increasing burden on healthcare providers.
The result is a real-world, healthcare-embedded research model capable of supporting preventative, interventional, and longitudinal outcome studies at scale.
The result is a real-world, healthcare-embedded research model capable of supporting preventative, interventional, and longitudinal outcome studies at scale.
Generate longitudinal real-world evidence
Stratify patients with precision using live clinical data
Evaluate disease progression or prevention over time
Accelerate recruitment into observational and interventional studies
Support post-marketing, HEOR, and payer-relevant evidence strategies
Advisory Board
Anchored by leading scientific experts
Asc Prof. Mark Toshner
Principal Investigator
Professor at the University of Cambridge, Director of the NIHR Clinical Research Facility in the VPD Heart & Lung Research Institute and an Honorary Consultant in Royal Papworth NHS Trust.
Prof. Naveed Sattir
Cardiometabolic Advisory Chair
University of Glasgow. Internationally recognised in cardiometabolic disease. Professor Sattar has contributed to multiple pharmaceutical trials and to eight national and international guidelines. He has co-authored over 1300 published papers
Security & Privacy
Setting a new standard for privacy & safeguarding
AccessCMD is run and maintained by Cohort Science, a clinical research organization
HIPAA compliant data management, IRB-approved patient consenting and patient-centric study design
Start building with ACCESS
Build Evidence That Moves Trials, Regulators, and Markets
Speak with our team to design a flexible, longitudinal real-world study that delivers the insight depth your programme needs.
hello@umed.io
hello@umed.io
Need help with something else?
Get in Touch
